Bermuda vs Grenada: The number of people with susceptibility test result for rifampicin
Bermuda
2
in 2021
Grenada
0
in 2021
Bermuda rank
143rd
Grenada rank
146th
The number of people with susceptibility test result for rifampicin over time
- Bermuda
- Grenada
How they compare
Bermuda currently reports 2 against 0 in Grenada, a difference of 2.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was Bermuda ahead.
Bermuda ranks 143rd and Grenada ranks 146th of 155 countries.
Bermuda has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Bermuda | Grenada | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1.33 | 0.6667 | 0.6667 | Bermuda |
| 2020s | 2 | 0 | 2 | Bermuda |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Bermuda or Grenada?
- Bermuda, at 2 against 0 in Grenada as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Bermuda and Grenada?
- 2, with Bermuda ahead.
- How many years of comparable data are there for Bermuda and Grenada?
- 5 years are reported by both, from 2017 to 2021.
- How do Bermuda and Grenada rank globally for the number of people with susceptibility test result for rifampicin?
- Bermuda ranks 143rd and Grenada ranks 146th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.